BASF sells Norway plant, focuses on pharma grade omega-3 products
BASF says the supply of API to GSK and other pharma customers will not be affected by the divestment of an omega-3 production plant in Norway.
Archives for November 24, 2014
Johnson Matthey: APIs down but Sigma-Aldrich acq could bring opportunities
The acquisition of Sigma-Aldrich by Merck KGaA could provide some opportunities for Johnson Matthey, the fine chemical company says as it reports a flat first half 2014/15.
German CMO looks to grow US biz through rise in SMEs and virtual pharma
Rottendorf is looking to break from being “the best kept secret in the CMO world” by targeting the thousands of virtual and SME pharma firms in the US, according to its CEO.
More details on Cetero/PRACS implosion come to light
Lachman Consultants has revealed more of the story behind the decline of the now bankrupt CRO Cetero/PRACS, which even though it’s shuttered, is still dealing with the fallout from its data integrity issues.
CROs mostly positive on proposed rule to make clinical trials more transparent
As part of a major transparency effort, the NIH (National Institutes of Health) and FDA are proposing to require the release of summary results of clinical trials for products that are unapproved or unlicensed.
$15k and API info: FDA releases guide to registering drug compounders
The US Food and Drug Administration (FDA) is encouraging hospitals to purchase their compounded drugs from organisations registered as outsourcing facilities, and has issued guidance on accreditation.
US, Chinese regulators forge closer ties as FDA looks to triple staff
As FDA commissioner Margaret Hamburg wraps up her trip in China it looks like the FDA is creating a stronger bond with its Chinese counterparts as the FDA looks to triple its staff there.